Apellis Pharmaceuticals, Inc. (FRA:1JK)
Germany · Delayed Price · Currency is EUR 20.13
-0.55 (-2.66%)
At close: Dec 19, 2025
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of €2.66 billion as of December 22, 2025. Its market cap has decreased by -33.98% in one year.
Market Cap
2.66B
Enterprise Value
2.66B
Revenue
866.28M
Ranking
n/a
PE Ratio
69.42
Stock Price
€20.13
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from 593.77M to 2.66B, an increase of 348.26%. That is a compound annual growth rate of 20.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 2.66B | -30.58% |
| Dec 31, 2024 | 3.83B | -40.26% |
| Dec 29, 2023 | 6.42B | 19.95% |
| Dec 30, 2022 | 5.35B | 32.19% |
| Dec 31, 2021 | 4.05B | 14.29% |
| Dec 31, 2020 | 3.54B | 103.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 129.76B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |